Jobs at the Center for Biologics Evaluation and Research (CBER)
CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics. Employment opportunities offer competitive salaries and excellent benefits. We invite you to apply for one of the positions listed below if you are seeking a challenging career opportunity.
Browse all FDA CBER positions on USAJOBS
For general information on qualifications for Medical Officers, scientists (Biologist, Chemist, Microbiologist, etc.), Consumer Safety Officers and other positions, please visit FDA’s Career Descriptions page.
CBER positions (other than those listed on USAJobs)
- CBER Title 21 Vacancy Announcement – Pharmacologist, AD-0405 - Band C, Office of Vaccines Research and Review (OVRR), Division of Clinical and Toxicology Review (DCTR), Toxicology Staff (TS)
Closes: April 19, 2024 - CBER Cures Vacancy Announcement – Branch Chief, AD-0696-Band D - Office of Compliance and Biologics Quality (OCBQ)/Division of Manufacturing and Product Quality (DMPQ)/Manufacturing Review Branch 1 (MRB1)
Closes: April 21, 2024 - CBER Cures Vacancy Announcement - Division Director, AD-0602-Band F, Office of Therapeutic Products (OTP), Office of Clinical Evaluation (OCE)
Closes: April 22, 2024 - CBER Title 21 Vacancy Announcement – Project Manager, AD-0301-Band B, Office of Regulatory Operations (ORO), Division of Regulatory Operations and Programs (DROP), Regulatory Programs Branch (RPB)
Closes: April 24, 2024 - CBER Cures Vacancy Announcement - Lead Physician, AD-0602-Band D, Office of Therapeutic Products (OTP), Division of Clinical Evaluation Hematology (DCEH), Benign Hematology Branch (BHB)
Closes: April 24, 2024 - Staff Fellow - Researcher-Reviewer
Closes: April 30, 2024 - Staff Fellow/Visiting Associate – Interdisciplinary Scientist
Closes: May 17, 2024 - Staff Fellow/Visiting Associate – Pharmacology/Toxicology Reviewer
Closes: June 30, 2024 - CBER Title 21 Vacancy Announcement – Physician, AD-Band C, Office of Therapeutic Products (OTP), Office of Clinical Evaluation (OCE), Division of Clinical Evaluation General Medicine (DCEGM), General Medicine Branch (GMB)
Closes: July 1, 2024 - CBER Title 21 Vacancy Announcement – Physician, Band C, Center for Biologics Evaluation and Research (CBER), Office of Biostatistics and Pharmacovigilance (OBPV), Division of Pharmacovigilance (DPV)
Open continuously - CBER Cures Vacancy Announcement – Physician, AD-0602-Band C, Office of Therapeutic Products (OTP)
Open continuously - CBER Title 21 Vacancy Announcement– Physician, AD-0602-Band C, Office of Vaccines Review and Research (OVRR), Division of Clinical and Toxicology Review (DCTR)
Open continuously
Fellowship Programs
- National Cancer Institute (NCI) and FDA Interagency Oncology Task Force (IOTF) Joint Fellowship Program
Offers fellowship training to a cadre of scientists in research and research-related regulatory review, policies, and regulations to develop a skill set bridging two distinct processes. - Oak Ridge Institute for Science and Education (ORISE) Research Participation Training Program for CBER
Provides temporary scientific training for domestic and foreign scientists having a background or interest in medical, biological, chemical, toxicological, mathematical/statistical, or other related sciences.
Related Information
- America's Veteran
- Hiring Programs
- Jobs at FDA
- Pathways Program (for students and recent graduates)
- 2024 Salary Tables and Related Information